Evidence map›Paper›PMID 31770479›Full record

ArticlePediatric pulmonology2020

Urinary club cell protein 16 (CC16): Utility of its assay during acute bronchiolitis.

Carole Egron, André Labbé, Emmanuelle Rochette, Aurélien Mulliez, Alfred Bernard, Amat Flore

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Pediatric pulmonology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Maternal smoking and CC-16: implications for lung development and COPD across the lifespan.American journal of respiratory and critical care medicine · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Corrigendum.Pediatric pulmonology · 2020
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Carole EgronDepartment of Pediatrics, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID 0000-0001-5832-3572
André LabbéDepartment of Pediatrics, CHU Clermont-Ferrand, University Clermont Auvergne, Clermont-Ferrand, France.
Emmanuelle RochetteDepartment of Clinical Research for Children (CRECHE) at CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID 0000-0001-5180-9916
Aurélien MulliezDepartment of Clinical Research and Innovation at CHU Clermont-Ferrand, Hospital Engineer, Clermont-Ferrand, France.
Alfred BernardLouvain Center of Toxicology and Applied Pharmacology, Catholic University of Louvain, Brussels, Belgium.ORCID 0000-0003-3171-3743
Amat FloreCenter of Asthma and Allergy, AP-HP, Groupe hospitalier Trousseau-La Roche Guyon, Pierre and Marie Curie University, Paris, France.ORCID 0000-0001-7843-7999
Centre Hospitalier Universitaire de Clermont-Ferrand · FRSorbonne Université · FRUCLouvain · BEUniversity of Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute bronchiolitis is responsible for high morbidity in infants. Club cell protein 16 kDa (CC16) is a major pneumoprotein secreted by club cells of the bronchial epithelium and eliminated by the renal pathway. CC16 seems to be a biomarker of epithelial damage in asthma. However, its value as a marker of acute bronchiolitis severity and later recurrent wheezing are uncertain, especially the value of its urinary assay for this purpose. A prospective, observational, analytical study was conducted at Clermont-Ferrand University Hospital to correlate serum CC16 level with clinical severity of bronchiolitis in hospitalized infants aged less than 1 year. We analyzed correlations between serum and urinary CC16, CC16 levels and Wainwright score, immediate morbidity due to bronchiolitis, causal viruses, and recurrent wheezing 1 year after inclusion. In 166 infants, serum CC16 did not correlate with acute bronchiolitis severity (P = .49), but urinary CC16 did (P < .001). In multivariate analysis, urinary CC16 correlated mainly with urinary retinol binding protein (RBP; r = 0.70; P < .001). The logCC16u/logRBPu ratio correlated significantly with severity (P = .02). CC16 levels were not correlated with recurrent wheezing at 1 year. Urinary CC16 could be a useful biomarker in acute bronchiolitis for specific indications. This noninvasive assay would be particularly useful in the young infant population. Several factors must be taken into account in its interpretation, mainly tubular function. Further studies are needed to assess these factors.

Indexed as

AsthmaBiological AssayBiomarkersBronchiolitisDiagnostic Tests, RoutineEpithelial CellsFemaleHumansInfantMaleMultivariate AnalysisProspective StudiesProteinsRespiratory SoundsUteroglobinBiomarkersProteinsUteroglobinacute bronchiolitisclub (Clara) cell proteininfantmorbidityseverity

Identifiers

PMID31770479
PMCPMC7167874
OpenAlexW2989796174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.